Tissue Regenix Group Share Price | |
---|---|
Price | 61.50 |
Bid | 61.00 |
Ask | 62.00 |
Change | 0.00 (0.00%) |
Volume | 61,694 |
Open | 62.00 |
High | 62.00 |
Low | 61.50 |
Prev. Close | 61.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 70.57m |
Market Capitalisation | £43.40m |
Market Size | 2,000 |
52 Week High | 71.50 |
52 Week High Date | 26-Feb-2024 |
52 Week Low | 49.00 |
52 Week Low Date | 03-Jul-2023 |
# Trades | 19 |
---|---|
Vol. Sold | 31,605 |
Sold Value | £19.30k |
Vol. Bought | 89 |
Bought Value | £N/A |
PE Ratio | -32.22282 |
Earnings | -1.908585 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 16:19:49 | 61.00 | 30,000 | Unknown* | 61.00 | 62.00 | 18.30k | O Ordinary Delayed publication |
25-Apr-24 | 16:16:12 | 61.00 | 50,000 | Unknown* | 61.00 | 62.00 | 30.50k | O Ordinary Delayed publication Historical |
26-Apr-24 | 16:22:14 | 61.38 | 584 | Sell* | 61.00 | 62.00 | 358.46 | O Ordinary |
26-Apr-24 | 13:01:36 | 61.00 | 8,277 | Sell* | 61.00 | 62.00 | 5,049 | O Ordinary |
26-Apr-24 | 13:00:49 | 61.10 | 8,277 | Sell* | 61.00 | 62.00 | 5,057 | O Ordinary |
26-Apr-24 | 11:49:57 | 61.40 | 1,144 | Sell* | 61.00 | 62.00 | 702.42 | O Ordinary |
26-Apr-24 | 11:49:57 | 61.00 | 1,159 | Sell* | 61.00 | 62.00 | 706.99 | O Ordinary |
26-Apr-24 | 10:01:20 | 61.05 | 2,000 | Sell* | 61.00 | 62.00 | 1,221 | O Ordinary |
26-Apr-24 | 10:00:36 | 61.05 | 9 | Sell* | 61.00 | 62.00 | 5.49 | O Ordinary |
26-Apr-24 | 09:35:34 | 61.00 | 6,052 | Sell* | 61.00 | 62.00 | 3,692 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
15-Sep-23 | 15-Sep-23 | Buy | Brian Phillips held the position of Independent Non-Executive Director at the time of this trade.Brian Phillips | 54.00 | GBX | 6,773 | 160,001 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.56 | GBX | 928,570 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.57 | GBX | 500,000 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.56 | GBX | 928,570 | 8,690,770 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.57 | GBX | 500,000 | 8,690,770 |
Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products.